Volume 139, Issue 6, Pages (December 2010)

Slides:



Advertisements
Similar presentations
Volume 2, Issue 10, Pages (October 2015)
Advertisements

Volume 133, Issue 1, Pages (July 2007)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Volume 139, Issue 3, Pages e8 (September 2010)
HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells  Sugiko Watanabe, Yasuaki Ueda, Shin-ichi Akaboshi,
Cell Physiol Biochem 2017;44:1867– DOI: /
Volume 131, Issue 4, Pages (October 2006)
Volume 68, Issue 1, Pages e6 (October 2017)
Volume 144, Issue 3, Pages e4 (March 2013)
Volume 145, Issue 2, Pages (August 2013)
Volume 141, Issue 1, Pages (July 2011)
Volume 145, Issue 4, Pages e9 (October 2013)
Volume 143, Issue 3, Pages e2 (September 2012)
Crucial Roles of MZF1 and Sp1 in the Transcriptional Regulation of the Peptidylarginine Deiminase Type I Gene (PADI1) in Human Keratinocytes  Sijun Dong,
Volume 132, Issue 5, Pages (May 2007)
DNMT3B Overexpression by Deregulation of FOXO3a-Mediated Transcription Repression and MDM2 Overexpression in Lung Cancer  Yi-Chieh Yang, MS, Yen-An Tang,
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Deregulation of SLIT2-Mediated Cdc42 Activity Is Associated with Esophageal Cancer Metastasis and Poor Prognosis  Ruo-Chia Tseng, PhD, Jia-Ming Chang,
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 133, Issue 1, Pages (July 2007)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 138, Issue 3, Pages e2 (March 2010)
Volume 145, Issue 4, Pages e9 (October 2013)
Volume 136, Issue 5, Pages (May 2009)
PTF1α/p48 and cell proliferation
Volume 140, Issue 7, Pages (June 2011)
Volume 146, Issue 7, Pages e5 (June 2014)
EPS15R, TASP1, and PRPF3 Are Novel Disease Candidate Genes Targeted by HNF4α Splice Variants in Hepatocellular Carcinomas  Monika Niehof, Jürgen Borlak 
Volume 142, Issue 3, Pages (March 2012)
Volume 76, Issue 1, Pages (July 2009)
Volume 135, Issue 1, Pages (July 2008)
Volume 141, Issue 6, Pages (December 2011)
Volume 132, Issue 5, Pages (May 2007)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Identification of a Hepatitis B Virus S Gene Mutant in Lamivudine-Treated Patients Experiencing HBsAg Seroclearance  Chao-Wei Hsu, Chau-Ting Yeh, Ming-Ling.
Volume 131, Issue 4, Pages (October 2006)
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 68, Issue 1, Pages e6 (October 2017)
Volume 128, Issue 1, Pages 9-23 (January 2005)
Volume 136, Issue 2, Pages (February 2009)
Volume 116, Issue 5, Pages (May 1999)
Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer  Sang Hoon Rhee, Eunok Im, Charalabos.
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Volume 139, Issue 3, Pages e8 (September 2010)
Rose-Anne Romano, Barbara Birkaya, Satrajit Sinha 
Volume 133, Issue 5, Pages (November 2007)
Volume 147, Issue 5, Pages (November 2014)
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 142, Issue 3, Pages e2 (March 2012)
Volume 145, Issue 2, Pages (August 2013)
Volume 140, Issue 3, Pages (March 2011)
Volume 5, Issue 4, Pages (April 2000)
Volume 142, Issue 7, Pages e2 (June 2012)
Volume 135, Issue 3, Pages e3 (September 2008)
Volume 22, Issue 2, Pages (February 2014)
Volume 3, Issue 2, Pages (February 2013)
Volume 21, Issue 12, Pages (December 2017)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
MiR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling  Hua Jin, Song Luo, Yun Wang, Chang Liu, Zhenghao.
14-3-3σ Regulates Keratinocyte Proliferation and Differentiation by Modulating Yap1 Cellular Localization  Sumitha A.T. Sambandam, Ramesh B. Kasetti,
Akito Maeshima, Yoshihisa Nojima, Itaru Kojima  Kidney International 
Volume 133, Issue 3, Pages (September 2007)
Volume 147, Issue 5, Pages (November 2014)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Volume 50, Issue 2, Pages (April 2013)
Volume 127, Issue 4, Pages (October 2004)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Klotho is a target gene of PPAR-γ
Long Noncoding RNA BC as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3  Jiaxin Lin, Xin Tan,
Presentation transcript:

Volume 139, Issue 6, Pages 2135-2145 (December 2010) KLF4α Up-regulation Promotes Cell Cycle Progression and Reduces Survival Time of Patients With Pancreatic Cancer  Daoyan Wei, Liwei Wang, Masashi Kanai, Zhiliang Jia, Xiangdong Le, Qiang Li, Huamin Wang, Keping Xie  Gastroenterology  Volume 139, Issue 6, Pages 2135-2145 (December 2010) DOI: 10.1053/j.gastro.2010.08.022 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Identification of KLF4 isoforms in pancreatic cancer cells. (A) A representative result of Northern blotting using mRNA from PANC-1 cells and a radiolabeled full-length KLF4 cDNA as a probe. Three bands were detected (arrows). (B) Total RNAs from different pancreatic cancer cell lines were used for RT-PCR analysis of KLF4 isoforms using the forward and reverse primers indicated in D. Several bands were detected in all cell lines tested. (C) mRNAs extracted from the cells indicated were used for RT-PCR analysis again; the individual sharp bands derived from PANC-1 cells in agarose gel were isolated and cloned into the pGEM-T easy vector. Plasmid DNAs extracted from at least 6 clones derived from each RT-PCR DNA band were DNA sequenced in both directions, with the results depicted in D. (D) Four KLF4 isoforms caused by cis-alternative splicing of KLF4 mRNA—KLF4α, KLF4β, KLF4γ, and KLF4δ—were identified in pancreatic cancer cells. The corresponding splicing site sequences are listed under each diagram; the letters in uppercase represent the exon part, and the letters in lowercase represent the intron part. The number of amino acid residuals deduced from the open reading frame of the individual isoform cDNAs is shown under the name of each isoform on the left side. Gastroenterology 2010 139, 2135-2145DOI: (10.1053/j.gastro.2010.08.022) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 Subcellular localization of KLF4α protein in culture cells. (A) A DsRed-tagged KLF4α expression vector was transfected into HEK293 cells and photographed under a fluorescent microscope for DsRed imaging (i) and 4′,6-diamidino-2-phenylindole nuclear staining (ii) 48 hours after transfection. An EGFP-tagged KLF4 expression vector was transfected into HEK293 cells as a control (iii). The A(iii) is the merge of A(i) and A(ii), whereas A(vi) is the merge of A(iv) and A(v). (B) Similarly, both DsRed-tagged KLF4α and EGFP-tagged KLF4 expression vectors were transfected into PANC-1 cells, respectively, and the corresponding images are shown in B(i) to B(vi). (C) Both nuclear and cytoplasmic proteins were extracted from HCT-116 cells 48 hours after transfection with FLAG-tagged KLF4α or FLAG-tagged KLF4 expression vector. The protein samples were used for Western blotting of FLAG-tagged protein expression. Protein sample loading was monitored by detection of glyceraldehyde-3-phosphate dehydrogenase and Histone H1 level, respectively. Gastroenterology 2010 139, 2135-2145DOI: (10.1053/j.gastro.2010.08.022) Copyright © 2010 AGA Institute Terms and Conditions

Figure 3 KLF4α expression in pancreatic cancer cells. (A) Real-time PCR primer and probe sets targeting the boundary of exons 2 to 4 or boundary 2 to 3 of KLF4 mRNA were selected or designed and shown to specifically detect KLF4α or wild-type KLF4 mRNA in FG cells transduced with control, KLF4, or KLF4 expression vector as indicated on the x-axis. (B) Differential expression of KLF4α and KLF4 in pancreatic cancer cell lines as determined using a real-time PCR under the conditions shown in A. (C) Real-time PCR analysis of relative KLF4α and KLF4 expression in pancreatic cancer cell lines with different metastatic potential. Note: the expression levels in the parental Colo357 cell line were used as a reference for comparison. (D) Real-time PCR analysis of KLF4α expression in human pancreatic tissue samples using a TissueScan Oncology qPCR Array of a panel of prenormalized cDNA samples. The relative KLF4α expression in pancreatic tumor (T) tissue was normalized according to the mean level of KLF4α (used as a reference) in 2 normal pancreatic tissue samples (N3 and N4). (E) Western blot analysis of specificity of anti-KLF4α antibody (GN330). Protein samples from HEK293 cells transfected with KLF4, KLF4α, or Flag-tagged KLF4α expression vector were used in immunoblot analysis with an H-180 (anti-KLF4) or KLF4α antibody. The results indicated that GN330 antibody specifically recognized KLF4α protein (E2, lanes 1 and 4) but not wild-type KLF4 (E2, lane 3), whereas the H-180 antibody recognized both KLF4 and KLF4α protein (E1, KLF4α: lanes 1 and 4; KLF4: lane 3). (F) Immunoprecipitation analysis of endogenous KLF4α protein expression in pancreatic cancer cells. Equal amounts of total cell lysates were immunoprecipitated with the H-180 antibody, and the precipitates were used for Western blot analysis with the KLF4α primary (GN330) antibody. Protein samples from HEK293 cells transfected with a KLF4α expression vector were used as positive controls (Po-Ctr) in Western blot analysis. Gastroenterology 2010 139, 2135-2145DOI: (10.1053/j.gastro.2010.08.022) Copyright © 2010 AGA Institute Terms and Conditions

Figure 4 Expression of KLF4α protein in pancreatic tissue and its association with survival. (A) Immunohistochemical analysis of KLF4α protein expression in pancreatic tissue samples with representative results showing KLF4α-negative (A[i], normal pancreatic tissue; A[ii], pancreatic tumor tissue) and KLF4α-positive (A[iii], pancreatic tumor tissue) staining. (B) Most of the normal samples (Non-T) exhibited no detectable KLF4α staining, whereas 23% of the pancreatic tumor samples (Tumor) exhibited KLF4α-positive staining. Pearson's 2-tailed χ2 test showed a significant statistical difference in KLF4α protein staining between the 2 tissue types (B[i], *P < .001). KLF4α-positive staining was associated with reduced durations in a Kaplan–Meier survival analysis of 22 patients with stage II pancreatic ductal adenocarcinoma (B[ii], P < .05; log-rank test). (C) IHC analysis of KLF4α and KLF4 protein expression in consecutive tissue microarray sections using KLF4α (GN330) and KLF4 antibodies that specifically recognized KLF4α and KLF4 protein, respectively (see Supplementary Figure 3). The difference between KLF4α and KLF4 protein expression was significant (C[i], *P < .001 by Pearson's 2-tailed χ2 test), and the representative staining results were shown (C[ii], case #1: negative KLF4 staining, strong positive KLF4α staining; case #2: weak KLF4 staining, positive KLF4α staining). Gastroenterology 2010 139, 2135-2145DOI: (10.1053/j.gastro.2010.08.022) Copyright © 2010 AGA Institute Terms and Conditions

Figure 5 KLF4α regulates cell cycle–related gene expression. (A) p27Kip1 promoter activity in HEK293 cells was measured 48 hours after transduction of the cells with KLF4α or a control vector using a dual luciferase assay. (B) Real-time PCR analysis of p27Kip1 expression in FG cells stably transduced with KLF4α or a GFP control gene and cultured in complete Dulbecco's modified Eagle medium containing 2% fetal calf serum for 24 hours. (C) Overexpression of KLF4α correlated with reduced expression of p27Kip1 protein in FG and BxPC-3 cells stably transduced with the KLF4α gene and cultured in complete Dulbecco's modified Eagle medium containing 2% fetal calf serum for 24 hours in Western blot analysis. (D) Forced expression of KLF4α correlated with reduced expressions of (D[i]) p27Kip1 mRNA and (D[ii]) protein in the pancreatic tumor tissue samples derived from the orthotopic mouse model. (E) Representative results of IHC staining for the detection of KLF4α p27Kip1 and proliferating cell nuclear antigen expression in the pancreatic tumor tissue samples derived from FG xenograft tumors. The lower panel of graphs shows the average scores of IHC staining evaluated from 6 independent high-power fields (original magnification 400×) for each group. *P < .05; **P < .01; ***P < .001 vs control or GFP. Gastroenterology 2010 139, 2135-2145DOI: (10.1053/j.gastro.2010.08.022) Copyright © 2010 AGA Institute Terms and Conditions

Figure 6 The effects of modulating KLF4α expression on cell growth and cell cycle progression in pancreatic cancer cells. (A) MTT analysis of (A[i]) FG and (A[ii]) BxPC-3 cell proliferation in the culture of complete Dulbecco's modified Eagle medium containing 2% fetal calf serum for 48 hours. (B and C) Cell cycle analysis of (B) FG and (C) BxPC-3 cells after culture in complete Dulbecco's modified Eagle medium containing 2% fetal calf serum for 24 hours. (D) Cell cycle analysis of L3.3 cells at 48 hours after mock, control small interfering RNA, or KLF4α small interfering RNA transfection. (E) In vivo pancreatic tumor growth. FG cells with forced KLF4α expression grew larger tumors than did FG cells transduced with a GFP control gene in orthotopic mouse models (E[i], representative tumor sizes; E[ii] and E[iii], mean tumor weight of 2 independent experiments). *P < .05 vs GFP control. Gastroenterology 2010 139, 2135-2145DOI: (10.1053/j.gastro.2010.08.022) Copyright © 2010 AGA Institute Terms and Conditions